Pricing Log in Create free account

MacroGenics, Inc. (MGNX) vs Satellos Bioscience Inc. (MSLE)

MacroGenics, Inc. and Satellos Bioscience Inc. are both Biotechnology companies. MacroGenics, Inc. and Satellos Bioscience Inc. are of similar size ($152.6M and $148.4M). Satellos Bioscience Inc. has the higher net margin (0.00% vs −8.70%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Satellos Bioscience Inc. leads on 8 and MacroGenics, Inc. on 3.

Valuation

Metric MGNX MSLE Biotechnology median
P/E n/m n/m 10.60
P/S 0.88 n/m 9.40
P/B 3.46 2.50 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.61 n/m 0.66
EV/Sales (0.11) n/m 9.02
Earnings yield (9.44%) (27.50%) (32.88%)
Free cash flow yield (44.23%) (19.37%) (23.13%)

Profitability

Metric MGNX MSLE Biotechnology median
Gross margin 85.23% — 68.51%
Operating margin (20.45%) 0.00% 0.00%
Net margin (8.70%) 0.00% 0.00%
Free cash flow margin (39.08%) 0.00% 0.00%
Return on equity (32.61%) (70.45%) (51.96%)
Return on assets (4.94%) (64.76%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MGNX MSLE Biotechnology median
Revenue growth (TTM) 1.32% — 6.76%
EPS growth (last fiscal year) (10.28%) 21.20% 29.88%
Revenue growth, 5-year CAGR 7.35% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MGNX MSLE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.96 11.22 4.97
Net debt to EBITDA 2.82 1.05 1.01

Dividend

Metric MGNX MSLE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MGNX MSLE Biotechnology median
Market cap 148.42m 152.57m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack